Ashleigh Palmer insider trades: Provention Bio (PRVB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ashleigh reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | PRVB | ↓ Sell | 75,835 | $10.09 | $765K | Direct | Feb 14, 2023 (1d) |
| Jan 18, 2023 | PRVB | ↓ Sell | 24,165 | $10.27 | $248K | Direct | Jan 20, 2023 (2d) |
| Nov 30, 2021 | PRVB | ↑ Buy | 3,750 | $6.66 | $25K | Direct | Dec 1, 2021 (1d) |
| Aug 18, 2020 | PRVB | ↑ Buy | 500 | $12.69 | $6K | Direct | Aug 18, 2020 (0d) |
| Aug 17, 2020 | PRVB | ↑ Buy | 2,800 | $12.83 | $36K | Direct | Aug 17, 2020 (0d) |
| Dec 20, 2019 | PRVB | ↑ Buy | 2,075 | $11.39 | $24K | Direct | Dec 23, 2019 (3d) |
| Sep 24, 2019 | PRVB | ↑ Buy | 3,000 | $8.38 | $25K | Direct | Sep 24, 2019 (0d) |
| Aug 8, 2019 | PRVB | ↑ Buy | 10,600 | $9.15 | $97K | Direct | Aug 9, 2019 (1d) |
| Jun 18, 2019 | PRVB | ↑ Buy | 4,000 | $10.83 | $43K | Direct | Jun 18, 2019 (0d) |
| Dec 31, 2018 | PRVB | ↑ Buy | 5,825 | $1.71 | $10K | Direct | Dec 31, 2018 (0d) |
| Jul 19, 2018 | PRVB | ↑ Buy | 37,500 | $4.00 | $150K | Direct | Jul 19, 2018 (0d) |
| Dec 21, 2011 | UGNE | ↑ Buy | 10,000 | $0.53 | $5K | Direct | Dec 22, 2011 (1d) |
| Sep 20, 2010 | UGNE | ↑ Buy | 8,800 | $0.70 | $6K | Direct | Sep 21, 2010 (1d) |
| Aug 12, 2010 | UGNE | ↑ Buy | 20,000 | $0.60 | $12K | Direct | Aug 12, 2010 (0d) |
| Jun 18, 2010 | UGNE | ↑ Buy | 21,200 | $0.80 | $17K | Direct | Jun 21, 2010 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ashleigh Palmer's insider trades
Ashleigh Palmer is Director and CEO at Provention Bio (PRVB). Since Jun 18, 2010, Ashleigh has reported 13 open-market purchases worth $457K and 2 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (2 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.